#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Epstein-Barr virus infection Desmoplastic small round cell tumour Burkitt's lymphoma Pancreatic carcinoma Congenital nephrogenic diabetes insipidus Ocular lymphoma Hereditary optic atrophy B precursor type acute leukaemia Crigler-Najjar syndrome Lung adenocarcinoma Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary motor and sensory neuropathy Inclusion body myositis Plasma cell myeloma refractory More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome Turner’s syndrome – Diagnostics Hereditary angioedema – Diagnostics Urea cycle disorder – Diagnostics Nodal marginal zone B-cell lymphoma – Treatment Glomerulonephritis membranoproliferative – Treatment Prader-Willi syndrome – Trials in Disease Chronic granulomatous disease Primary mediastinal large B-cell lymphoma – Trials in Disease Sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metamizole Albaconazole Prucalopride Insulin Icodec 99MTC-EUK-(SO3)CY5-MAS3 Quinine Dihydrochloride Mometasone Furoate Lutetium (177Lu)-Neobomb1 Atropine Sulfate Gsk3915393 Meropenem Trihydrate Spiramycin RIKKUNSHITO Gefurulimab Diclofenac Sodium GSKVX000000030825 Trabectedin Piperacillin Monohydrate Gfh925 LY4170156 More therapies…

    Learn about Your Condition

    Hip fracture Arterial tortuosity syndrome Liposarcoma Autoimmune uveitis Dystonia Ewing's sarcoma recurrent Hypochromic anaemia Mastocytosis Cardiac ventricular thrombosis Viral myocarditis Hepatic angiosarcoma Procedural haemorrhage Red blood cell abnormality Arthritis infective Fibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular seminoma (pure) stage I
    Investigated Drugs:
    • Bleomycin
    • Carboplatin
    • Cisplatin
    Norway Sweden

  • Study Comparing Oral Amoxicillin to Outpatient IV Antibiotics for Patients with Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Investigated Drugs:
    • Amoxicillin
    Spain

  • Study of TCR-Modified T Cell Therapy with ANOC-001, ANOC-002, and ANOC-003 for Adults with Advanced Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANOC-001
    Denmark Germany The Netherlands Sweden

  • Study on the Safety and Effectiveness of Inclisiran in Children Aged 2 to Under 12 with Homozygous Familial Hypercholesterolemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Inclisiran
    Austria France Germany Greece The Netherlands Spain

  • Study on Oxytocin and Mindfulness Training for Reducing Stress in Adults with Psychological Distress

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on EXL01 for Preventing Crohn’s Disease Recurrence After Surgery in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Exl01
    France
Previous Page
1 … 259 260 261 262 263 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!